These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9759939)

  • 1. Evaluating the potential of germ line transmission after intravenous administration of recombinant adenovirus in the C3H mouse.
    Ye X; Gao GP; Pabin C; Raper SE; Wilson JM
    Hum Gene Ther; 1998 Sep; 9(14):2135-42. PubMed ID: 9759939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses.
    Raper SE; Haskal ZJ; Ye X; Pugh C; Furth EE; Gao GP; Wilson JM
    Hum Gene Ther; 1998 Mar; 9(5):671-9. PubMed ID: 9551615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse.
    Paielli DL; Wing MS; Rogulski KR; Gilbert JD; Kolozsvary A; Kim JH; Hughes J; Schnell M; Thompson T; Freytag SO
    Mol Ther; 2000 Mar; 1(3):263-74. PubMed ID: 10933942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No evidence for germ-line transmission following prenatal and early postnatal AAV-mediated gene delivery.
    Jakob M; Mühle C; Park J; Weiss S; Waddington S; Schneider H
    J Gene Med; 2005 May; 7(5):630-7. PubMed ID: 15693035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence of germ-line transmission by adenovirus-mediated gene transfer to mouse testes.
    Kojima Y; Hayashi Y; Kurokawa S; Mizuno K; Sasaki S; Kohri K
    Fertil Steril; 2008 May; 89(5 Suppl):1448-54. PubMed ID: 17624347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
    Ji L; Bouvet M; Price RE; Roth JA; Fang B
    Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated hepatic gene transfer in mice: comparison of intravascular and biliary administration.
    Peeters MJ; Patijn GA; Lieber A; Meuse L; Kay MA
    Hum Gene Ther; 1996 Sep; 7(14):1693-9. PubMed ID: 8886840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of ornithine transcarbamylase deficiency in adult spf(ash) mice and in OTC-deficient human hepatocytes with recombinant adenoviruses bearing the CAG promoter.
    Kiwaki K; Kanegae Y; Saito I; Komaki S; Nakamura K; Miyazaki JI; Endo F; Matsuda I
    Hum Gene Ther; 1996 May; 7(7):821-30. PubMed ID: 8860834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated in vivo gene transfer rapidly protects ornithine transcarbamylase-deficient mice from an ammonium challenge.
    Ye X; Robinson MB; Pabin C; Quinn T; Jawad A; Wilson JM; Batshaw ML
    Pediatr Res; 1997 Apr; 41(4 Pt 1):527-34. PubMed ID: 9098855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the human and mouse amino-terminal leader peptides of ornithine transcarbamylase affect mitochondrial import and efficacy of adenoviral vectors.
    Ye X; Zimmer KP; Brown R; Pabin C; Batshaw ML; Wilson JM; Robinson MB
    Hum Gene Ther; 2001 Jun; 12(9):1035-46. PubMed ID: 11399226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus vector-mediated gene transfer to regional lymph nodes.
    Labow D; Lee S; Ginsberg RJ; Crystal RG; Korst RJ
    Hum Gene Ther; 2000 Mar; 11(5):759-69. PubMed ID: 10757355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors.
    Morral N; O'Neal W; Zhou H; Langston C; Beaudet A
    Hum Gene Ther; 1997 Jul; 8(10):1275-86. PubMed ID: 9215744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes.
    Morsy MA; Alford EL; Bett A; Graham FL; Caskey CT
    J Clin Invest; 1993 Sep; 92(3):1580-6. PubMed ID: 8376608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct exposure of mouse ovaries and oocytes to high doses of an adenovirus gene therapy vector fails to lead to germ cell transduction.
    Gordon JW
    Mol Ther; 2001 Apr; 3(4):557-64. PubMed ID: 11319918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer.
    Raper SE; Chirmule N; Lee FS; Wivel NA; Bagg A; Gao GP; Wilson JM; Batshaw ML
    Mol Genet Metab; 2003; 80(1-2):148-58. PubMed ID: 14567964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Autoreplication' of the vector genome in recombinant adenoviral vectors with different E1 region deletions and transgenes.
    Marienfeld U; Haack A; Thalheimer P; Schneider-Rasp S; Brackmann HH; Poller W
    Gene Ther; 1999 Jun; 6(6):1101-13. PubMed ID: 10455413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient depletion of CD4 lymphocyte improves efficacy of repeated administration of recombinant adenovirus in the ornithine transcarbamylase deficient sparse fur mouse.
    Ye X; Robinson MB; Pabin C; Batshaw ML; Wilson JM
    Gene Ther; 2000 Oct; 7(20):1761-7. PubMed ID: 11083498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas-mediated apoptosis is involved in the elimination of gene-transduced hepatocytes with E1/E3-deleted adenoviral vectors.
    Okuyama T; Li XK; Funeshima N; Fujino M; Sasaki K; Kita Y; Kosuga M; Takahashi M; Saito H; Suzuki S; Yamada M
    J Gastroenterol Hepatol; 1998 Sep; 13 Suppl():S113-8. PubMed ID: 9792044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline incorporation of a replication-defective adenoviral vector in mice does not alter immune responses to adenoviral vectors.
    Camargo FD; Huey-Louie DA; Finn AV; Sassani AB; Cozen AE; Moriwaki H; Schneider DB; Agah R; Dichek DA
    Mol Ther; 2000 Nov; 2(5):496-504. PubMed ID: 11082323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single short stretch of homology between adenoviral vector and packaging cell line can give rise to cytopathic effect-inducing, helper-dependent E1-positive particles.
    Murakami P; Pungor E; Files J; Do L; van Rijnsoever R; Vogels R; Bout A; McCaman M
    Hum Gene Ther; 2002 May; 13(8):909-20. PubMed ID: 12031124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.